Search results
Results from the WOW.Com Content Network
Adalimumab, sold under the brand name Humira and others, is a disease-modifying antirheumatic drug and monoclonal antibody used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis.
Sign in to your AOL account to access your email and manage your account information.
Use the Sign-in Helper to locate your username and regain access to your account by entering your recovery mobile number or alternate email address.; To manage and recover your account if you forget your password or username, make sure you have access to the recovery phone number or alternate email address you've added to your AOL account.
From or to a drug trade name: This is a redirect from (or to) the trade name of a drug to (or from) the international nonproprietary name (INN).
Humira, the brand name of adalimumab, is an anti-TNF antibody discovered by CAT as D2E7, then developed in the clinic and marketed by Abbvie, formerly Abbott Laboratories. CAT was also behind belimumab , the anti-BlyS antibody drug marketed as Benlysta and the first new approved drug for systemic lupus in more than 50 years. [ 1 ]
The U.S. market share for Humira biosimilars stands at nearly 20%, compared with 2.2% in the first quarter of this year, Barclays analysts said in a note on Monday.
Sometimes the old "turn it off and on again" actually works. In this case, try completely signing out of your account then sign back in. Many times, this will help, especially in cases of bad passwords or some simple browser issues.
Humira is without a doubt the most important drug for AbbVie . In the first quarter, sales of Humira were $2.2 billion, making up more than half of total sales. Expanding the drug into axial ...